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The first step in assembling immunoglobulin and T-cell receptors by V(D)J recombination has similarities to
transposon excision. The excised transposon-like element then integrates into DNA targets at random in vitro,
but whether this activity significantly threatens the genomic integrity of its host has been unclear. Here, we
recover examples where the putative transposon associated with V(D)J recombination integrated into the
genome of a pre-B-cell line. Transposition accounted for a surprisingly high proportion (one-third) of
integrations, while most of the remaining events had parallels to other aberrant V(D)J recombination
pathways linked to oncogenic translocation. In total, transposition occurred approximately once every 50,000
V(D)J recombinations. Transposition may thus contribute significantly to genomic instability.
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The mammalian immune system’s mature antigen-spe-
cific receptor genes are assembled during lymphocyte de-
velopment by a rearrangement of separate coding seg-
ments [V(D)J recombination]. V(D)J recombination is ini-
tiated when the RAG1 and RAG2 proteins cleave
chromosomal DNA at a pair of conserved recombination
targeting signals that flank coding segments. The non-
homologous end-joining (NHEJ) pathway for repair of
chromosome breaks then joins the ends of coding seg-
ments (coding ends) together to form the mature receptor
gene, as well as typically joining signal-containing ends
(signal ends) together to generate an extrachromosomal
circle (for review, see Gellert 2002). RAG proteins use a
transposase-like mechanism to cleave chromosomal
DNA at recombination signals (van Gent et al. 1996).
Importantly, the signal end fragment excised by RAG
protein cleavage activity can also be likened to a trans-
poson. It has been demonstrated that RAG proteins can
direct the integration of this fragment into DNA targets
approximately at random (e.g., Fig. 1A) in vitro (Agrawal
et al. 1998; Hiom et al. 1998), in yeast cells (Clatworthy
et al. 2003), and even in mammalian cells (Chatterji et al.
2006).
Association of transposition activity with V(D)J re-
combination suggests a possible source for the oncogenic
translocations observed in lymphoid malignancies. Pre-
viously, these translocations were attributed in part to
aberrant joining of a broken intermediate in V(D)J recom-
bination to a spontaneous break within an oncogene lo-
cus. More recently, RAG protein activities that are not
targeted by canonical recombination signals have been
proposed as a less arbitrary source for the breakpoint in
the oncogene locus (Hiom et al. 1998; Raghavan et al.
2004). With respect to transposition activity, for ex-
ample, it has been suggested that RAG proteins could
initiate recombination at a site within a receptor locus,
but then “transpose” one end of the receptor locus
double-strand break into a target site near an oncogene
(one-ended transposition) (Hiom et al. 1998).
However, whether V(D)J recombination-associated
transposition activity could be a significant source of
genomic instability is not yet clear. Studies of transpo-
sition activity in cellular contexts indicate it is infre-
quent (Clatworthy et al. 2003; Chatterji et al. 2006), and
have been limited to measuring targeting of transposi-
tion into artificial episomes: As yet, there is only one
clear example where a transposition-event targeted its
host genome (Messier et al. 2003). Therefore, we address
here whether or not the transposon-like fragment ex-
cised during V(D)J recombination can significantly target
its host genome. Moreover, to more closely mimic V(D)J
recombination in the whole animal, we used a mouse
pre-B-cell line as host, and a chromosomally resident re-
combination substrate. The substrate was further de-
signed to determine the frequency of genomic integra-
tion of the excised fragment as a function of each exci-
sion: This is the key measure of the danger posed by
V(D)J recombination-associated transposition, as the ex-
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cision step is implicit in development of each mature
lymphocyte. Our results implicate V(D)J recombination-
associated transposition activity as an important pos-
sible source of oncogenic rearrangements.
Results
The substrate (Fig. 1A) was arranged such that a gene for
puromycin resistance (puror) was interrupted by the pu-
tative transposable fragment: an intact gene for zeocin
resistance (a zeocin-binding protein–green fluorescent
protein fusion, or zeorGFP), flanked by one each of the
pair of recombination targeting signals required for a
V(D)J recombination event (a 12-RS [12-type recombina-
tion signal] and a 23-RS [23-type recombination signal]).
The puromycin coding sequences flanking the signals
were further adjusted to reduce the frequency of junc-
tions that fail to confer puromycin resistance (see Mate-
rials and Methods for details). Puromycin resistance
identifies cells that have successfully initiated V(D)J re-
combination, joined the ends of the puromycin coding
region together (analogous to assembling the mature re-
ceptor gene), and have excised the potential transposon.
The ends of the excised fragment are normally ligated
together to form a circle, but this extrachromosomal
circle is not maintained as cells continue to grow. Sub-
cloning of cells in both puromycin and zeocin thus en-
riches for cells where the fragment instead reintegrated
into the genome. Additional screening by flow analysis
for GFP expression, PCR analysis of DNA, and finally
Southern blotting was used to definitively identify
clones that had reintegrated the putative transposon as-
sociated with substrate V(D)J recombination (Fig. 1B,C,
Supplementary Fig. 1).
The temperature-sensitive Abelson Murine Leukemia
virus (ts-AMuLV) line used as a host can be induced in
culture to undergo multiple developmental steps analo-
gous to the in vivo transition from pre-B cells to imma-
ture B cells (Muljo and Schlissel 2003), including initia-
tion of V(D)J recombination at its endogenous immuno-
globulin  (Ig) light-chain locus (Chen et al. 1994).
Three different recombination substrate-containing
clones were generated from the initial ts-AMuLV line,
and multiple experiments were performed with each
clone. We were unable to detect any significant differ-
ences between different clones or experiments in our
current sample; thus, only the pooled results are dis-
cussed (see Table 1; Materials and Methods for differ-
ences in clones and experimental conditions). In total, 21
subclones were identified that had reintegrated the pu-
tative transposon, from a total of 2.2 × 107 cells screened
(Table 1). Parallel assessments of cells resistant only to
puromycin determined that 2.8 × 105 of the screened
cells had undergone productive V(D)J recombination.
The transposon-like fragment associated with V(D)J re-
combination thus reintegrates into the genome approxi-
mately once every 1.3 × 104 recombinations.
The selection scheme used does not distinguish be-
tween different integration pathways. However, authen-
tic transposition products have a characteristic struc-
ture; thus, the location and junction structure for each
integration was determined using inverse PCR (Table 2;
Figs. 2–6). In RAG-mediated transposition in vitro, the 3
ends of the two signals are joined to opposite strands of
Figure 1. Recovery of integrations of a transposon-like frag-
ment. (A) The assay for recovering potential transposon integra-
tions is described. (Boxes) Coding sequence; (filled triangle) 12-
type recombination signal (12-RS); (open triangle) 23-type re-
combination signal (23-RS); (puror) intact gene for puromycin
resistance; (zeorGFP) fusion gene that confers zeocin resistance
and green fluorescence. In B and C, DNA from subclones resis-
tant to puromycin and zeocin after induction of V(D)J recombi-
nation (numbered as in Table 2) were digested with EcoRI (cuts
once 5 of the puror gene) and PstI (cuts only in flanking chro-
mosomal DNA), Southern blotted, and analyzed with a probe
from the puror gene (B) or zeorGFP gene (C). DNA from the
parental line (P) and the initial clone with unrearranged sub-
strate (clone A) are included for comparison. The mobility of
molecular weight markers (in kilobase pairs) are shown at the
right of each panel.












A 3.0 7.8 6 (3) 7.7 (3.8)
A* 0.6 0.19 2 (1) 11 (5.3)
B 11 8.8 2 (0) 2.3 (0)
C 7.5 11 11 (3) 10 (2.7)
Total 22 28 21 (7) 7.5 (2.5)
aThree clones were used, varying as described in Materials and
Methods. In one experiment using clone A*, cells were exposed
to 0.5 Gy  radiation immediately after induction of recombi-
nation.
bThe number of cells screened expected to be at least puromycin
resistant, based on frequencies of resistance to puromycin only
determined in parallel assays.
c Efficiencies are the reintegration frequency or, in parentheses,
transposition frequency, as a fraction of the total puror cells
screened.
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a target DNA duplex 4–5 base pairs (bp) apart, resulting
in the precise insertion of the signal end fragment and a
characteristic 4–5 bp direct repeat of flanking target
DNA (target site duplication) (Fig. 2A,B). Six of the 21
integrations had such a structure (Fig. 2A). In addition,
target sequences typically had a locally high GC content,
in agreement with previously characterized RAG-medi-
ated transpositions (Hiom et al. 1998; Clatworthy et al.
2003; Tsai et al. 2003; Chatterji et al. 2006). Target sites
were otherwise distributed throughout the genome, al-
though, interestingly, two of the six transpositions (in-
tegrations #5 and #6) (Fig. 2A) were located within a re-
gion of GC-rich pentanucleotide repeats (Sµ repeat re-
gion) that targets immunoglobulin H (IgH) isotype
switch recombination. Southern blotting indicated there
were no rearrangements of the Sµ region in the other
induced subclones, arguing switch recombination is not
highly active in this pre-B-cell line (Y.V.R. Reddy and
D.A. Ramsden, unpubl.). It is tempting to speculate in-
stead that the richness of secondary structure-forming
sequences in this region (e.g., G quartets, hairpins) (Gel-
lert et al. 1962; Tashiro et al. 2001) might make this
region a transposition “hot spot” (see also integration #7,
below).
One additional event can be attributed to an alterna-
tive transposition mechanism (integration #7) (Fig.
3A,B). Strikingly, both signal ends integrated into chro-
mosome 5, in the middle of an ∼100-bp (CA)N–(TG)N
inverted repeat. Hairpins that form at inverted repeat
sequences are preferred targets for RAG-mediated trans-
position in vitro (Lee et al. 2002), and hairpin-targeted
transposition might partly explain a complex rearrange-
Table 2. Location of integration sites
Clonea Integration #
12-RSS flank 23-RS flank
Accession no. Position Accession no. Position
A 1 AC026478 13041 AC026478 13037
A 2 AL606914 41953 rcb AL606914 41956 rcb
C 3 AC141471 184523 AC141471 184519
C 4 AC126023 31830 rcb AC126023 31833 rcb
A 5 AC073553 137778 AC073553 137775
A 6 AC073553 ∼139000c AC073553 ∼139000c
C 7 AC115293 76224d AC115293 762324
C 8 AC109232 109804 M29209 (env)e 591
C 9 AC126608 103234 rcb AF010170 (gag)e 2773
C 10 AL604022 31535 rcb AL604022 31525 rcb
A 11 AC109138 164160 AC109138 164242
C 12 AY591724 2131 AY591724 2134
A 13 AC079273 45819 AC079273 45821
C 14 AC073561 160089 AC073553 133793
B 15 AY591618 2521 L80040 1098
B 16 AY591667 1805 L80040 2066
A 17 AC153615 59540 rcb AY591668 1735 rcb
C 18 L80040 744 rcb AY591682 1788 rcb
A 19 AY591727 1648 AY591727 383
C 20 L80040 1731 rcb AY591725 1629
C 21 AY591620 1769 rcb AY591682 1737 rcb
aThe initial substrate-containing clone (A, B, or C; see also Table 1) that was used to generate integration-containing subclones.
bThe position of flanking nucleotides are reported as “rc” (reverse complement) when the 12-RS and 23-RS are inserted in the opposite
orientation relative to that of the published sequence.
cThe flanking sequences recovered for clone #6 by inverse PCR contained only canonical pentanucleotide switch µ repeats, and thus
they could be placed in multiple different locations within AC073553. Additionally, Southern analysis indicated germline fragment
sizes were ∼2 kbp larger than that predicted from the sequence in AC073553, in accordance with reports that this region is highly
polymorphic in different mouse strains (Marcu et al. 1980). Further characterization of this clone by Southern analysis allowed us to
determine that both 12-RS and 23-RS flanks were located ∼1 kbp further away from the heavy-chain intron enhancer than the
corresponding flanks of subclone #5, and that the subclone #6 integration was not accompanied by significant (>200 bp) deletion of
genomic DNA flanking the integration site. Additionally, we note that at least in the reported switch µ region, the sequence TGGGG
is never tandemly repeated; thus, together with the lack of significant deletion as determined by Southern analysis, we argue the
structure of the subclone #6 integration is best explained by a transposition event.
dSequences of the microsatellite targeted for integration from the parent clone (clone C) argued for polymorphism in this region
relative to accession AC115293, and possibly within the population of clone C as well. The indicated positions were thus determined
from a best-fit alignment to sequence from AC115293.
eFor subclones #8 and #9, the 23-RS flanks contain only sequence from Moloney Murine leukemia virus genes (MoMuLV). There are
no pre-existing MoMuLV proviruses near the regions identified by the12-RS flanks in published sequence, suggesting viral DNA may
have “cointegrated” with the zeorGFP fragment. However, we cannot exclude the possibility that deletion of flanking sequence during
integration was sufficient to extend into a distally located provirus, or even that there is a pre-existing proviral integration in this
region that is novel to the SP9 line’s strain background.
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ment recovered from human cells (Messier et al. 2003).
Additionally, RAG proteins can mediate a reversal of the
initial cleavage reaction by inserting signal ends into
hairpin coding end intermediates in vitro (Melek et al.
1998), and, under certain conditions, in vivo (Bogue et al.
1997; Sekiguchi et al. 2001). However, the presence of a
target site duplication cannot be used to identify this
type of event as a transposition, and inverted repeat se-
quences are generally associated with chromosome
breakage.
We therefore determined if the chromosome 5 in-
verted repeat sequence was sufficient to target transpo-
sition activity in vitro. We incubated a purified RAG
protein signal end complex with a plasmid containing a
415-bp fragment of the chromosome 5 sequence as it was
prior to integration of the zeorGFP fragment. Of 16 in
vitro transposition products, 12 integrated near the tip of
the predicted hairpin, close (within 11 bp) to the cellular
integration sites (Fig. 3C). This is a 30-fold greater fre-
quency than would be expected by chance. For compari-
son, we performed a similar experiment using a chromo-
some 7 fragment that included the site of an integration
that was neither associated with a flanking target site
duplication nor an inverted repeat (#8) (Fig. 4). Using the
chromosome 7 fragment as a target for in vitro transpo-
sition, integration sites were more dispersed (Fig. 3, cf. D
and C), and were not generally near the site of cellular
integration. Therefore, integration into the chromosome
5 inverted repeat is consistent with transposition tar-
geted to a hairpin-forming sequence.
In sum, there are seven integrations attributable to
RAG-mediated transposition, or approximately one
transposition every 50,000 V(D)J recombinations (Table
1). We might have expected the remaining events that
were not consistent with transposition also to be ran-
domly distributed throughout the genome. Only four of
the remaining 14 integrations fit into this category (Fig.
4). The cause of these integrations is unclear, but the
most probable explanation is that the zeorGFP fragment
was captured during repair of a spontaneous double-
strand break. The remaining 10 events are more easily
explained: All of the integration sites for these events
were located <60 bp away from sites broken during V(D)J
recombination of immunoglobulin (Ig) loci. As described
below, these 10 integrations can be further classified as
either intermolecular recombinations (Fig. 5) or end do-
nations (Fig. 6), the two aberrant V(D)J recombination
pathways previously proposed to cause the transloca-
tions associated with lymphoid malignancy (for review,
see Roth 2003).
In three of these integrations (Fig. 5A), one of the sig-
Figure 3. Integration into an inverted repeat. (A) The structure
of integration #7 is summarized as in Figure 2A. (B) Pathway for
integration by transposition into a hairpin-forming sequence.
Ovals represent RAG proteins. (C) A 415-bp chromosome 5 frag-
ment that contained the targets for cellular integration #7 is
represented as a line. The termini of the cloned fragment are
defined by nucleotide numbers that map to the sequence in
accession AC115293. The approximate location of (CA)N and
(TG)N repeats within this fragment are noted by thick lines (see
also footnote d of Table 2). The locations of cellular integration
sites are noted above the line, while the locations of in vitro-
defined integrations are noted with open triangles below the
line. (D) Seven-hundred base pairs of a chromosome 7 fragment
(from AC109232) that contained the target for cellular integra-
tion #8 are represented as in C. The site of integration of the
12-RS of the zeorGFP fragment is noted above the line. The
23-RS flank could not be located in this region (see footnote e of
Table 2).
Figure 2. Integrations consistent with transpositions. (A) For
each of the identified integration events (#, numbered as in
Table 2) we report the number of base pairs deleted from 12-RS
and 23-RS ends of the zeorGFP fragment (RS 12/23), the chro-
mosome where the fragment integrated (Ch.), a brief description
of genomic DNA immediately flanking 12-RS ends and 23-RS
ends, and the amount of genomic DNA between integration
flanks ( genomic DNA). The sequences of flanking target site
duplications are in bold. At the bottom is a graphic summariz-
ing the typical integration structure. (*) As described in detail in
footnote c of Table 2, the repetitive nature of sequences flanking
integration #6 did not allow for unambiguous location of flanks
within the region. (B) Pathway for integration by transposition.
Ovals represent RAG proteins.
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nal ends of the zeorGFP fragment was joined to an Ig or
IgH signal end of the opposite type, generating a precise
12-RS/23-RS-type signal junction. The remaining signal
end of the zeorGFP fragment was imprecisely joined to a
Ig/IgH coding end. These integrations can be attributed
to intermolecular recombination. The RAG proteins
mistakenly juxtaposed a signal from the Ig or IgH locus
with a signal of opposite type from the zeorGFP fragment
(intermolecular synapsis) (Fig. 5B), triggering cleavage at
the Ig/IgH signal. The zeorGFP signal may have been
part of a signal junction circle that is recleaved as a con-
sequence of the intermolecular synapsis (as shown in
Fig. 5B), as there is precedent for secondary recombina-
tions involving a signal within a signal junction (Lewis
et al. 1985). However, we cannot exclude the possibility
that signal junction fomation is unnecessary, and a
zeorGFP signal end participated in synapsis with, and
triggered cleavage of, the IgH signal. In any event, inte-
gration is the consequence of the subsequent resolution
of all four broken ends by NHEJ, as described in Figure
5B. Importantly, the intermolecular recombinations de-
scribed here can be likened to those that occur between
a signal within an antigen receptor locus and a cryptic
signal within an oncogene locus (Fig. 5C), leading to a
subset of cancer-causing translocations. In both cases,
the critical aberrant step is the inappropriate intermo-
lecular synapsis of signals by RAG proteins.
Seven other examples also involve targeting of integra-
tion to Ig loci (Fig. 6A). However, only one of the 14
junctions from these integrations involves two signals
(integration #21), and joining was never precise (numbers
of nucleotides deleted from Ig ends are noted in paren-
theses in Fig. 6A). Instead, zeorGFP signal ends were of-
ten perfectly retained and usually joined to ends of Ig
coding segments (coding ends) with short deletions, a
pattern consistent with previous examples of NHEJ-de-
pendent joining of comparable ends (Sekiguchi et al.
2001). Broken intermediates from a single V(D)J recom-
bination event are normally joined by NHEJ to each
other (joining in cis): In these seven events, joining in cis
apparently failed, both for the signal end intermediates
from recombination at the substrate locus, as well as for
the intermediates from an independent recombination
occurring in parallel within the Ig locus. Instead, the
intermediates from these two independent recombina-
tions were joined to each other in trans (Fig. 6B). Such
events are comparable to oncogenic “end donations,”
where intermediates from an antigen receptor recombi-
nation are joined to the ends of a double-strand break
generated independently within an oncogene locus (Fig.
6C). The critical aberrant step in both examples is the
failure of NHEJ to join broken ends in cis, leading instead
to inappropriate joining of broken ends in trans.
Discussion
Integrations of the transposon-like fragment could thus
often be explained by one or the other of the two aberrant
recombination pathways mechanisms previously associ-
ated with oncogenic translocation (intermolecular re-
combination or end donation). Does the high proportion
(one-third) of transpositions thus implicate transposition
activity as an important additional source of oncogenic
translocations? The assay described here is specific for
integrations involving a signal end pair, a restriction that
was essential for definitive identification of transposi-
tions. Recovery of transpositions will thus be favored
relative to other integration pathways. However, we will
also not score the kinds of transpositions (Hiom et al.
1998) best reconciled with oncogenic translocations (e.g.,
one-ended transpositions, cycles of integration, and ex-
cision). Indeed, these alternate transposition pathways
were initially proposed because they can generate aber-
Figure 4. Other nontargeted integrations. The structures of in-
tegration #8–11 are summarized as in Figures 2A and 3A. A
possible inserted nucleotide (nontemplated) is noted in lower-
case. (*) Sequences flanking the 23-RS for #8 and #9 were de-
rived from Moloney Murine leukemia virus genes, and could
not be located near the 12-RS flanks. (See also footnote e of
Table 2.)
Figure 5. Integration by intermolecular V(D)J recombination.
(A) The structure of integrations #12–14 are summarized as in
Figures 2–4. Rectangles represent flanking immunoglobulin (Ig)
locus coding segments, and triangles represent flanking Ig locus
recombination signals. The numbers in parentheses within
these symbols refer to the base pairs of the genomic sequence
deleted relative to the site of RAG protein cleavage. (*) Integra-
tion #14 is the product of two recombinations, as described in
Supplementary Figure 2. B and C describe how intermolecular
recombination can similarly lead to both integration of the
zeorGFP fragment (B) as well as translocations between receptor
loci and oncogene (onc) loci (C). Ovals represent RAG proteins,
while boxes represent NHEJ proteins.
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rant rearrangement structures that are mostly indistin-
guishable from those previously attributed to end dona-
tion. Therefore, with respect to the oncogenic potential
of transposition, we consider it noteworthy that at least
when transpositions can be definitively identified, trans-
position competes effectively with the two pathways
previously used to explain oncogenic translocation. Per-
haps more importantly, transposition was the primary
means (7/11 events) by which signal end intermediates
were resolved in a near-random, and thus potentially on-
cogenic, manner. In contrast, the probable intermolecu-
lar recombinations and end donations we recovered were
mostly targeted to a recombining locus, and conse-
quently made “safe.”
Several characteristics of our assay argue for its bio-
logical relevance. The use of a substrate where the trans-
poson donor was chromosomally integrated was prob-
ably critical. It has not been possible to recover transpo-
sitions in cellular genomes from an episome-based
donor, and transposition between episomes appears to be
much less efficient (Chatterji et al. 2006). Additionally,
we used a cell line of lymphocyte lineage, and conse-
quently native RAG1 and RAG2 proteins, expressed un-
der native transcriptional control. As noted above, con-
current recombination activity at Ig loci also led to other
biologically relevant aberrant resolutions, allowing us to
assess how well transposition competes with such
events. Recombination activity was also not excessive,
as ∼15% of light chain loci (and ∼3% of substrate loci)
recombined in the 24-h period during which recombina-
tion was active. Nevertheless, transposition frequencies
in a whole animal could still be significantly different.
For example, we might be overestimating transposition
in vivo due to characteristics of this transformed cell line
model (e.g., probable disruption of DNA damage check-
points). Alternatively, our assay might underestimate
transposition in vivo, as it is unlikely we recover all
integrations (the ability to express sufficient zeorGFP to
survive selection is probably highly dependent on inte-
gration context).
Is V(D)J recombination-associated transposition an im-
portant threat to genomic integrity? At least under con-
ditions where transpositions can be definitively identi-
fied, we show it accounts for a high proportion of aber-
rant V(D)J recombinations. We estimate there are
2.5 × 10−5 events associated with each V(D)J recombina-
tion. For comparison, the well-characterized sleeping
beauty transposon, which has been engineered to muta-
genize the mouse genome, transposes in embryonic stem
cells with similar or lower frequency (3.5 × 10−5 to
2 × 10−7 events/cell/generation) (Luo et al. 1998). Hu-
mans generate several hundred million new lympho-
cytes/day, with each new lymphocyte requiring at least
three V(D)J recombination events. Our data would thus
suggest this daily output of lymphocytes is accompanied
by as many as 10,000 transpositions: in all liklihood, an
important potential source of oncogenic genome rear-
rangements.
Materials and methods
Constructs and cell lines
The substrate was derived from amplified fragments of pPUR
and pTRACER-EF plasmids (Clontech), and assembled as de-
scribed in Figure 1 within a murine stem cell virus-based ret-
rovirus vector (Cheng et al. 1998). Diversity in coding junction
formation could potentially lead to infrequent puromycin resis-
tance, reducing the sensitivity of our assay. Therefore, since
NHEJ often precisely deletes repeated sequence at ends during
coding junction formation, we designed the substrate such that
the 4 bp of the puromycin coding sequence immediately flank-
ing recombination signals was repeated. Sequencing of coding
junctions formed in the absence of selection indicated the pu-
romycin ORF was precisely assembled in three out of five V(D)J
recombinations.
Retrovirus was prepared by cotransfection of the substrate
plasmid together with plasmids expressing gag, pol, and vsv-g
genes into 293T cells (Pear et al. 1993). Virus recovered from the
supernatant was used to infect the ts-AMuLV line SP-9 (gift of
Y. Chang, University of New Mexico, Albuquerque, NM)
(Chang and Brown 1999). Clones were obtained by limiting di-
lution plating in media with 100 µg/mL zeocin, and those with
unique, single-copy integrations were identified by Southern
blotting of genomic DNA from zeor colonies. The construct
used to generate clones A and B possessed a deletion of 1 nucleo-
Figure 6. Integration by end donation. (A) The structure of
integrations #15–21 are summarized as in Figures 2–5. Rect-
angles represent flanking Ig locus coding segments, and tri-
angles represent flanking Ig locus recombination signals. The
numbers in parentheses within these symbols refer to the base
pairs of the genomic sequence deleted relative to the site of
RAG protein cleavage. (*) Sequence flanks a cryptic 23-type
signal within the V region: CACtGTG (23 bp) AgAAAAACC
(nucleotides that match consensus RS in capital letters). B and
C describe how end donation can similarly lead to both integra-
tion of the zeorGFP fragment (B) as well as translocations be-
tween receptor loci and onc loci (C). Boxes represent NHEJ pro-
teins.
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tide (nt) within the 23-RS nonconserved spacer. This is within
the ±1-bp natural variation of spacer size used in vivo; thus, we
continued study of lines made with this construct, but addition-
ally corrected the substrate and generated a line with a consen-
sus spacer size 23-RS (Clone C). The integrated version of the
substrate in Clone A also has a 400-bp deletion between the
12-bp spacer RS and zeorGFP reading frame that apparently had
no significant impact on zeorGFP expression.
Screening colonies
Cells were washed once and V(D)J recombination induced in the
absence of both puromycin and zeocin by transfer to 40°C for 24
h. Induced cultures were then returned to preinduction condi-
tions to recover for 24 h, still without antibiotics. Cells were
then subcloned by plating in 96-well plates at 2 × 103 cells/plate
in media with 5 µg/mL puromycin alone [to determine the fre-
quency of productive V(D)J recombination], or at 105 cells/plate
in 5 µg/mL puromycin and 100 µg/mL zeocin. Screening by flow
analysis indicated a small proportion of subclones that survived
in zeocin nevertheless had green fluorescence indistinguishable
from background (within 10% of the median fluorescence in-
tensity of the parental line). This indicates cells can infre-
quently acquire zeocin resistance by means other than mainte-
nance of the zeorGFP cassette: Later analysis of DNA from se-
lected zeor, GFP negative clones by PCR (Supplementary Fig.
3A, P4/P7) confirmed the absence of the zeorGFP cassette. DNA
was prepared from the remaining clones and analyzed by PCR to
confirm coding junction formation (assembly of a complete
puromoycin gene) (Supplementary Fig. 3A, P2/P9), as well as
loss of the “germline” 5 puro fragment–recombination signal–
zeorGFP configuration (Supplementary Fig. 3A, P2/P5).
The majority of puror–zeor clones were eliminated from fur-
ther analysis when they tested positive for both coding junction
and “germline” PCR products. Southern analysis of selected
clones of this type determined this was due to apparent dupli-
cation of the substrate in an estimated 1% of the parental line
prior to induction of recombination: Upon induction of recom-
bination in these cells, one copy recombined, conferring puro-
mycin resistance to the cell, while the remaining copy remained
in the unrecombined configuration, allowing the cell to also
retain resistance to zeocin. Such duplications may have been
caused by mobilization of our proviral substrate by a helper
virus in trans, or possibly unequal sister chromaid exchange at
proviral long terminal repeats.
The 21 puror–zeor subclones remaining after screening by
PCR analysis were then analyzed by Southern blotting, and con-
firmed to have a pattern consistent with transposition; that is,
relative to the clone before recombination, a 5 puro hybridizing
species showed evidence of transposon excision (∼2 kb smaller)
(Fig. 1B; Supplementary Fig. 1A,C,E), while zeorGFP hybridizing
species were of a distinct size, but varied essentially at random
(Fig. 1C; Supplementary Fig. 1B,D,F). ZeorGFP (543 bp) and Puro
(423 bp) probe fragments for Southern blot analysis were gener-
ated by PCR amplification of substrate with primer pairs P3/P8
and P1/P6, respectively (Supplementary Fig. 3). Each probe frag-
ment was radiolabeled with 32P-dCTP by two rounds of an-
nealing with appropriate primers and extension with klenow
polymerase. Hybridizations were performed in buffer with 50%
formamide at 43°C for the zeorGFP probe and 49°C for the Pu-
romycin probe using standard protocols.
In vitro transposition
The in vitro transposition reactions were performed as previ-
ously described, using the same oligonucleotide recombination
signals and PCR primers (Lee et al. 2002), except we used as
target plasmid cloned chromosomal sequences that acted as cel-
lular targets for integrations #7 and #8. Briefly, a complex of
recombinant core RAG1 and RAG2 proteins, HMG1, and oli-
gonucleotide recombination signals was first formed by prein-
cubation in the presence of CaCl2. Cleavage of recombination
signals and transposition was then initiated by addition of
MgCl2 and 0.8 µg of plasmid target. Integrations of cleaved sig-
nals were then PCR-amplified from deproteinized reactions us-
ing a primer in the recombination signal and a primer in the
plasmid target. Target plasmid carried through the transposition
and PCR reactions was then inactivated by digestion with DpnI
before PCR products were cloned (TOPO-TA, Invitrogen). Con-
sistent with integration by a transposition mechanism, we re-
covered only integrations of accurately cleaved recombination
signals, despite using oligonucleotide signals with flanking
“coding” sequence.
Characterization of junctions
Junction sequences were cloned by inverse PCR. Briefly, ge-
nomic DNA was first enriched for fragments with integrations
by separating EcoRI-digested genomic DNA by electrophoresis
on a 0.8% agarose gel, followed by recovery of DNA of molecu-
lar weight appropriate to species with integrations as deter-
mined by prior Southern analysis. This DNA was then digested
with HaeIII or MspI, ligated with T4-DNA ligase at 0.25–0.5
µg/mL, amplified by 25 cycles using the 12R1/12F1 and 23F1/
23R1 primer pairs (Supplementary Fig. 3B), diluted 50-fold, and
amplified again for 25 cycles with 12R2/12F2 and 23F2/23R2
(Supplementary Fig. 3B). PCR products were then cloned using
a TOPO-TA cloning kit (Invitrogen) and sequenced. We then
used the sequences derived from inverse PCR to design primers
that permitted direct amplification of integration junctions.
PCR primers
The following primers were used for PCR amplifications; their
approximate position within our substrate is noted in Supple-
mentary Figure 3: (5–3) P1, CCAGCCGGGAACCGCTCAA
CT; P2, CGAGCTGCAAGAACTCTTCCTCAC; P3, CTCCAA
TTGGCGATGGCCCTGTCC; P4, GGTCACGCTTTTCGTT
GGGATCTTTCG; P5, TACTCAGACAATGCGATGGG; P6,
GAATTCTAGGCTTTTGCAAAAAGCTT; P7, AGATGACG
GGAACTCCAAGACGC; P8, ATAAACAAGTTTCGAGGTC
GAGTGTCAGTC; P9, CGCTCGTAGAAGGGGAGGTT; 12R1,
GCCAGGCGGGCCATTTACCGTA; 12R2, TACTCAGACAA
TGCGATGGG; 12R3, GAAATCCCCGTGAGTCAAAC; 12F1,
GACGCAAATGGGCGGTAGGC; 12F2, GTACGGTGGGAG
GTCTATAT; 23R1, GTAACCATTATAAGCTGCAATAAAC;
23R2, GAGGTCGAGTGTCAGTCCTGC; 23F1, TCACTGCA
TTCTAGTTGTGGTTTG; 23F2, GTGGTTTGTCCAAACTC
ATCAATG.
PCR reactions using P2/P9 required inclusion of 1 M betaine
(Sigma).
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